Gray Foundation’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Gray Foundation's ASND Position: Q4 2024 in Review
Gray Foundation sold out of Ascendis Pharma (ASND) in Q4 2024, closing a stake of 51,700 shares — an estimated $7.72M sold.
Gray Foundation first reported a position in ASND in Q4 2023 and held it in 4 quarters. The position peaked at $7.82M in Q1 2024. 214 funds tracked by Wall St. Rank hold ASND as of Q4 2024.
- Gray Foundation reported no remaining Ascendis Pharma position as of Q4 2024 after selling out during the quarter.
- Gray Foundation sold 51,700 Ascendis Pharma shares in Q4 2024, an estimated $7.72M.
- Gray Foundation first reported a position in Ascendis Pharma in Q4 2023 and held it in 4 quarters.
- Gray Foundation's Ascendis Pharma position peaked at $7.82M in Q1 2024.
- 214 funds tracked by Wall St. Rank held Ascendis Pharma as of Q4 2024.
Based on Gray Foundation's 13F filing for Q4 2024, filed 4 Feb 2025.